Eversept Partners, LP Sutro Biopharma, Inc. Transaction History
Eversept Partners, LP
- $991 Million
- Q4 2024
A detailed history of Eversept Partners, LP transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 694,408 shares of STRO stock, worth $1.23 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
694,408
Previous 1,841,989
62.3%
Holding current value
$1.23 Million
Previous $6.37 Million
79.96%
% of portfolio
0.13%
Previous 0.5%
Shares
7 transactions
Others Institutions Holding STRO
# of Institutions
128Shares Held
59.9MCall Options Held
203KPut Options Held
33.6K-
Suvretta Capital Management, LLC New York, NY7.46MShares$13.2 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$12.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$7.45 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.64MShares$6.45 Million0.42% of portfolio
-
Vestal Point Capital, LP New York, NY2.57MShares$4.55 Million0.28% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $92.3M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...